Eris acquires 51 pc stake in Swiss Parenterals for Rs 637.5 cr

Eris Lifesciences on Tuesday said it has acquired a 51 per cent stake in Swiss Parenterals for Rs 637.5 crore. Ahmedabad-based Swiss Parenterals is a leading player in the sterile injectables business in over 80 emerging markets across Africa, the Asia Pacific and Latin America.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news